GGrantIndex
Sort

17,828 grants matching crispr

Convergent Drivers of Tumor Evolution at the Mitotic Spindle

$571,724
Frank M Mason · Vanderbilt University Medical Center · R01 · FY2025 · CA

Development of Advanced Preclinical Models for Pediatric Solid Tumors

$571,418
Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2024 · CA

Role of Smooth Muscle Calponin in Vascular Pathobiology

$571,166
Joseph M Miano · Augusta University · R01 · FY2020 · HL

Gut Treg cells at the microbiome interface

$571,091
Christophe O Benoist · Harvard Medical School · R01 · FY2025 · AI

The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia

$570,945
Marcus Dasilva Goncalves · New York University School Of Medicine · OT2 · FY2024 · CA

Next Generation IgH-reprogramming for in vivo delivery

$570,870
Shannon Marie Miller · Scripps Research Institute, The · P01 · FY2025 · HL

(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)

$570,843
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

$570,759
Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

$570,759
Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2016 · CA

Targeting c-Myc stability in c-Myc overexpressing large B-cell lymphoma

$570,593
Lapo Alinari · Ohio State University · R01 · FY2025 · CA

Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease

$570,535
Hayk Davtyan · University Of California-Irvine · R01 · FY2021 · AG

The pathogenic effects of epithelial cells surviving direct influenza virus infection

$570,450
Nicholas S Heaton · Duke University · R01 · FY2019 · AI

Genetics and Pathobiology of Cutaneous Mosaic Disorders

$570,288
Keith A Choate · Yale University · R01 · FY2021 · AR

Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV

$570,279
Peter Jesse Gaskill · Drexel University · R61 · FY2023 · DA

Credentialing Models of Invasive Lobular Breast Cancer for Translational Research

$570,252
Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

CRISPR logic circuits for safer and controllable gene therapies

$570,195
Samira Kiani · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · EB

Understanding the variation of induced β-cell differentiation.

$570,026
Yan Li · Case Western Reserve University · R01 · FY2024 · DK

Diagnostic Innovations for Pediatric Tuberculosis in Bolivia

$570,008
Richard A Oberhelman · Tulane University Of Louisiana · R01 · FY2025 · AI

Using genomic perturbations to understand trait-associated human genetic variation

$570,000
Graham McVicker · Salk Institute For Biological Studies · R35 · FY2024 · HG

Using genomic perturbations to understand trait-associated human genetic variation

$570,000
Graham McVicker · Salk Institute For Biological Studies · R35 · FY2021 · HG

Using genomic perturbations to understand trait-associated human genetic variation

$570,000
Graham McVicker · Salk Institute For Biological Studies · R35 · FY2025 · HG

Using genomic perturbations to understand trait-associated human genetic variation

$570,000
Graham McVicker · Salk Institute For Biological Studies · R35 · FY2022 · HG

Using genomic perturbations to understand trait-associated human genetic variation

$570,000
Graham McVicker · Salk Institute For Biological Studies · R35 · FY2023 · HG

Metabolomics of cGVHD

$569,841
Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2023 · HL

Collaborative Research: Molecular Mechanisms Underlying Repeated Evolution: Integrating Micro- and Macroevolutionary Analyses and Functional Genomics

$569,812
Michael Tobler · University Of Missouri-Saint Louis · · FY2023 · BIO